These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 27105782)
1. The Immunogenicity of CRISP1 Plasmid-Based Contraceptive Vaccine can be Improved When Using Chitosan Nanoparticles as the Carrier. Luo J; Liu XL; Zhang Y; Wang YQ; Xu WM; Yang J Am J Reprod Immunol; 2016 Jun; 75(6):643-53. PubMed ID: 27105782 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity study of plasmid DNA encoding mouse cysteine-rich secretory protein-1 (mCRISP1) as a contraceptive vaccine. Luo J; Yang J; Cheng Y; Li W; Yin TL; Xu WM; Zou YJ Am J Reprod Immunol; 2012 Jul; 68(1):47-55. PubMed ID: 22429321 [TBL] [Abstract][Full Text] [Related]
3. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine. Chehelgerdi M; Doosti A J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems. Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097 [TBL] [Abstract][Full Text] [Related]
5. Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection. Huang T; Song X; Jing J; Zhao K; Shen Y; Zhang X; Yue B J Nanobiotechnology; 2018 Jan; 16(1):8. PubMed ID: 29378591 [TBL] [Abstract][Full Text] [Related]
6. Optimization of Chitosan-α-casein Nanoparticles for Improved Gene Delivery: Characterization, Stability, and Transfection Efficiency. Panão Costa J; Carvalho S; Jesus S; Soares E; Marques AP; Borges O AAPS PharmSciTech; 2019 Feb; 20(3):132. PubMed ID: 30820699 [TBL] [Abstract][Full Text] [Related]
7. Non-Conjugated Chitosan-Based Nanoparticles to Proteic Antigens Elicit Similar Humoral Immune Responses to Those Obtained with Alum. Izaguirre-Hernández IY; Mellado-Sánchez G; Mondragón-Vásquez K; Thomas-Dupont P; Sánchez-Vargas LA; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Vivanco-Cid H J Nanosci Nanotechnol; 2017 Jan; 17(1):846-52. PubMed ID: 29634187 [TBL] [Abstract][Full Text] [Related]
8. Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E. Wei W; Behloul N; Wang W; Baha S; Liu Z; Shi R; Meng J Macromol Biosci; 2021 Apr; 21(4):e2000375. PubMed ID: 33624916 [TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity and transfection efficiency of pDNA encoded p53 gene-loaded chitosan-sodium deoxycholate nanoparticles. Hashem FM; Nasr M; Khairy A; Alqurshi A Int J Nanomedicine; 2019; 14():4123-4131. PubMed ID: 31239671 [No Abstract] [Full Text] [Related]
10. A novel PEGylation of chitosan nanoparticles for gene delivery. Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512 [TBL] [Abstract][Full Text] [Related]
11. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259 [TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response. Pawar D; Jaganathan KS Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494 [TBL] [Abstract][Full Text] [Related]
13. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Zhao K; Zhang Y; Zhang X; Li W; Shi C; Guo C; Dai C; Chen Q; Jin Z; Zhao Y; Cui H; Wang Y Int J Nanomedicine; 2014; 9():389-402. PubMed ID: 24426783 [TBL] [Abstract][Full Text] [Related]
14. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier. Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436 [TBL] [Abstract][Full Text] [Related]
16. [Synthesis and characterization of chitosan-DNA nanoparticles as gene carriers]. Su D; Ji AM Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):595-8. PubMed ID: 17545064 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles. Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445 [TBL] [Abstract][Full Text] [Related]
18. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant. Mehrabi M; Dounighi NM; Rezayat Sorkhabadi SM; Doroud D; Amani A; Khoobi M; Ajdary S; Pilehvar-Soltanahmadi Y Artif Cells Nanomed Biotechnol; 2018; 46(sup1):230-240. PubMed ID: 29260901 [TBL] [Abstract][Full Text] [Related]
19. Construction of the plasmid pCMV4-rZPC' DNA vaccine and analysis of its contraceptive potential. Xiang RL; Zhou F; Yang Y; Peng JP Biol Reprod; 2003 May; 68(5):1518-24. PubMed ID: 12606447 [TBL] [Abstract][Full Text] [Related]
20. Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells. Hallaj-Nezhadi S; Valizadeh H; Dastmalchi S; Baradaran B; Jalali MB; Dobakhti F; Lotfipour F J Pharm Pharm Sci; 2011; 14(2):181-95. PubMed ID: 21733408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]